First Time Loading...
Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 32.35 CNY 2.47% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one Qingdao Baheal Medical Inc stock under the Base Case scenario is 46.4 CNY. Compared to the current market price of 32.35 CNY, Qingdao Baheal Medical Inc is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
46.4 CNY
Undervaluation 30%
Relative Value
Price
Q
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
16
vs Industry
47
Median 3Y
1.9
Median 5Y
1.9
Industry
2.4
Forward
2.1
More Details
26
P/E
P/E
Price to Earnings
26
vs History
62
vs Industry
22
Median 3Y
27.4
Median 5Y
27.4
Industry
23.2
Forward
25.8
More Details
43.4
P/OCF
P/OCF
Price to OCF
43.4
vs History
40
vs Industry
8
Median 3Y
39.9
Median 5Y
39.9
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
7
Median 3Y
37.5
Median 5Y
37.5
Industry
23.5
More Details
7.3
P/B
P/B
Price to Book Value
7.3
vs History
16
vs Industry
10
Median 3Y
6.2
Median 5Y
6.2
Industry
2.2
More Details
2.4
EV/S
EV/S
Enterprise Value to Sales
2.4
vs History
16
vs Industry
45
Median 3Y
1.9
Median 5Y
1.9
Industry
2.5
Forward
2.3
More Details
8.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.2
vs History
21
vs Industry
28
Median 3Y
7.3
Median 5Y
7.3
Industry
5.2
More Details
20.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.3
vs History
54
vs Industry
16
Median 3Y
20.3
Median 5Y
20.3
Industry
12.5
Forward
18.6
More Details
20.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.3
vs History
54
vs Industry
24
Median 3Y
20.3
Median 5Y
20.3
Industry
17.2
Forward
19.5
More Details
45.7
EV/OCF
EV/OCF
Enterprise Value to OCF
45.7
vs History
43
vs Industry
7
Median 3Y
42.9
Median 5Y
42.9
Industry
15.1
More Details
63.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
63.3
vs History
43
vs Industry
7
Median 3Y
59.3
Median 5Y
59.3
Industry
19.7
More Details
4.9
EV/IC
EV/IC
Enterprise Value to IC
4.9
vs History
29
vs Industry
18
Median 3Y
4.5
Median 5Y
4.5
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Qingdao Baheal Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Qingdao Baheal Medical Inc
SZSE:301015
17B CNY 2.3 26 20.3 20.3
US
Mckesson Corp
NYSE:MCK
68.7B USD 0.2 22.9 15.9 18.5
US
Cencora Inc
NYSE:COR
44.5B USD 0.2 23.8 12.2 17.2
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD 0.1 20.9 11.3 15.2
US
Cardinal Health Inc
NYSE:CAH
24.2B USD 0.1 37.8 8.5 11.4
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
US
Henry Schein Inc
NASDAQ:HSIC
8.8B USD 0.7 21.3 11.3 15.2
CN
Huadong Medicine Co Ltd
SZSE:000963
57.6B CNY 1.4 21.3 15.5 15.5
CN
Sinopharm Group Co Ltd
HKEX:1099
61.2B HKD 0.1 6.3 1.5 1.8
IT
Amplifon SpA
MIL:AMP
7.2B EUR 3.2 46.6 15 29.6
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
51B CNY 0.2 13.5 8 8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.